COVAXIN
COVID-19 Vaccine Precaution Dose: Bharat Biotech Seeks DCGI's Permission to Conduct Covaxin Booster Trials in 2-18 Age Group
Bharat Biotech Must Address WHO's COVID-19 Vaccine Covaxin Supply Suspension to Avoid Emergency Use Listing Cancellation in Future, Says MEA
COVID-19 Vaccine: DCGI Grants Emergency Use Authorisation to ZycovD for Above 12-Year-Olds, Corbevax for Children Aged 5–12
COVID-19 in India: Bharat Biotech's 'Covaxin' Gets Emergency Use Authorisation for Children Between 6-12 Years
COVID-19 in India: Bharat Biotech Asked To Provide More Data on 'Covaxin' for Below 12-Year-Olds
Bharat Biotech to Rectify Issues Raised by WHO on COVID-19 Vaccine Covaxin Soon: Sources
No Impact of WHO Action on COVID-19 Vaccine Covaxin, Have Not Supplied to Any UN Agency, Says Bharat Biotech
Bill Gates Applauds Indian Vaccine Manufacturers for Supplying Affordable Vaccines Across the World
COVID-19 Vaccine for Children: Ensure Only Covaxin Is Given to 15–18 Group, Says Bharat Biotech
Mansukh Mandaviya Launches Stamp to Mark 1 Year of COVID-19 Vaccination Drive, Says 70% Adults Fully Vaccinated
COVAXIN Booster Dose Trial Demonstrates Long-Term Safety With No Serious Adverse Events, Says Bharat Biotech
Google Trends